Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BLCO stock hub

Bausch + Lomb Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BLCOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

BLCO

In the news

Latest news · BLCO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.4

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-5.4

P25 -105.6P50 -46.5P75 -3.1

ROIC1.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BLCO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001860742
Company name	Bausch + Lomb Corporation
Country	Canada
Country code	US
Cusip	071705107
Employees	13,000
Employees Change	-500%
Employees Change Percent	-3.7
Enterprise value	$10.6B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2022-05-06
Isin	CA0717051076
Last refreshed	2026-05-10
Market cap	$5.8B
Market cap category	Mid-Cap
Price	$16.18
Price currency	USD
Rev Per Employee	392,384.62x
Sector	Healthcare
Sic	3851
Symbol	BLCO
Website	https://www.bausch.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.24%
EV Sales Forward	1.92x
EV/EBIT	56.53x
EV/EBITDA	17.45x
EV/Sales	2.08x
FCF yield	-1.14%
Forward P/E	18.39x
P/B ratio	0.89x
P/S ratio	1.13x
PEG ratio	0.47x
PS Forward	1.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.69%
EBITDA Margin	11.94%
Gross margin	59.81%
Gross Profit	$3.1B
Gross Profit Growth	4.52%
Gross Profit Growth Q	11.94%
Gross Profit Growth3 Y	10.7%
Gross Profit Growth5 Y	7.48%
Net Income	$-360M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6.21%
Profit Margin	-7.06%
Profit Per Employee	$-27,692
ROA	0.85
Roa5y	1.21
ROCE	1.55
ROE	-5.39
Roe5y	-2.26
ROIC	1.67
Roic5y	1.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	41.96%
Cagr3y	-2.58%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	21.98%
OCF Growth Q	518.18%
OCF Growth3 Y	-6.39%
OCF Growth5 Y	-11.52%
Revenue Growth	6.47x
Revenue Growth Q	9.77x
Revenue Growth Quarters	13x
Revenue Growth Years	5x
Revenue Growth3 Y	10.62x
Revenue Growth5 Y	8.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$14B
Cash	$383M
Current Assets	$3B
Current Liabilities	$1.9B
Debt	$5.2B
Debt EBITDA	$7.79
Debt Equity	$0.8
Equity	$6.5B
Interest Coverage	0.45
Liabilities	$7.5B
Long Term Assets	$11B
Long Term Liabilities	$5.6B
Net Cash	$-4.9B
Net Cash By Market Cap	$-84.32
Net Debt EBITDA	$7.98
Net Debt Equity	$0.75
Tangible Book Value	$-1.6B
Tangible Book Value Per Share	$-4.49
WACC	6.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	2.04
Net Working Capital	$751M
Quick ratio	0.84
Working Capital	$1.1B
Working Capital Turnover	$4.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.57%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	41.93%
200-day SMA	15.95
3Y total return	-7.54%
50-day SMA	16.43
50-day SMA vs 200-day SMA	50over200
All Time High	21.95
All Time High Change	-26.29%
All Time High Date	2023-06-30
All Time Low	10.45
All Time Low Change	54.83%
All Time Low Date	2025-04-30
ATR	0.5
Beta	0.59
Beta1y	1.39
Beta2y	0.93
Ch YTD	-5.27
High	16.31
High52	18.92
High52 Date	2026-02-25
High52ch	-14.46%
Low	15.67
Low52	10.99
Low52 Date	2025-05-23
Low52ch	47.23%
Ma50ch	-1.54%
Price vs 200-day SMA	1.44%
RSI	50.07
RSI Monthly	50.53
RSI Weekly	49.45
Sharpe ratio	1.12x
Sortino ratio	1.9
Total Return	-0.57%
Tr YTD	-5.27
Tr1m	1.63%
Tr1w	-0.8%
Tr3m	-4.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	1
Analyst Price Target Top	$21
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.05
Earnings Revenue Estimate	1,212,561,704x
Earnings Revenue Estimate Growth	6.65x
Operating Income	$188M
Operating Income Growth	-8.74
Operating Income Growth Q	83.72
Operating Income Growth3 Y	-5.1
Operating Income Growth5 Y	-8.74
Operating margin	3.69
Price target	$18.36
Price Target Change	$13.47
Price Target Change Top	$29.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,633,043%
Float Percent	12.52%
Net Borrowing	261,000,000
Shares Insiders	0.36%
Shares Institutions	10.92%
Shares Out	356,382,628
Shares Qo Q	0.06%
Shares Yo Y	0.57%
Short Float	8.31%
Short Ratio	8.99
Short Shares	1.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-215M
Average Volume	441,928x
Bv Per Share	18.2
CAPEX	$-349M
Ch1m	1.63
Ch1w	-0.8
Ch1y	41.93
Ch3m	-4.82
Ch3y	-7.54
Ch6m	4.05
Change	1.7%
Change From Open	1.31
Close	15.91
Days Gap	0.38
Depreciation Amortization	421,000,000
Dollar Volume	9,601,859.2
Earnings Date	2026-04-29
Earnings Time	bmo
EBIT	$188M
EBITDA	$609M
EPS	$-1.02
F Score	4
FCF	$-66M
FCF EV Yield	-0.62x
FCF Per Share	$-0.19
Financing CF	225,000,000
Fiscal Year End	December
Founded	1,853
Goodwill	4,758,000,000
Income Tax	$35M
Investing CF	-455,000,000
Ipr	-10.11
Iprfo	-12.54
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-02-18
Ma150	16.41
Ma150ch	-1.4%
Ma20	16.18
Ma20ch	-0.01%
Net CF	81,000,000
Next Earnings Date	2026-07-29
Open	15.97
Optionable	Yes
P OCF Ratio	20.38
Position In Range	79.69
Post Close	16.18
Postmarket Change Percent	-0.31
Postmarket Price	$16.13
Ppne	1,922,000,000
Price Date	2026-05-08
Price EBITDA	$9.47
Relative Volume	1.34x
Revenue	5,101,000,000x
SBC By Revenue	2.92x
Share Based Comp	149,000,000
Tax By Revenue	0.69x
Tr6m	4.05%
Volume	593,440
Z Score	0.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BLCO pay a dividend?

Capital-return profile for this ticker.

Performance

BLCO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BLCO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.9%

Float: +12.5% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BLCO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.1

Neutral momentum band

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BLCO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BLCO stock rating?

Bausch + Lomb Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BLCO analysis?

The full report lives at /stocks/BLCO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BLCO?

The latest report frames BLCO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BLCO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.